Key points are not available for this paper at this time.
This multicenter study identifies insights into the risk factors, clinical features, histopathologic findings, and renal and overall outcomes in patients with immune checkpoint inhibitor-associated AKI.
Cortazar et al. (Thu,) studied this question.